Targeting LRRC15-expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseases

Rheumatology · Published 2026-06-01 · DOI 10.1093/rheumatology/keag293

Authors (17)

Xintao Tu, Thao-Nguyen Bach, Arjun Baghela, Mark Zielstorff, William Smallridge, Qian Chen, Soha Motlagh, Travis Barr, Marc Alexander Sze, In Sock Jang, Jie Zhang-Hoover, Alex M Tamburino, Vanessa M Peterson, Rajesh V Kamath, Marc C Levesque, Karin Vroom, Nidhi Malhotra

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Tu, X., Bach, T., Baghela, A., et al. (2026). Targeting LRRC15-expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseases. Rheumatology. https://doi.org/10.1093/rheumatology/keag293

Related articles